高负担社区筛查中Xpert Ultra痰标本「微量」结果提示结核病的证据
在乌干达坎帕拉对≥15岁人群进行系统性Ultra结核筛查,211/21957(1.0%)阳性,其中96例(46%)为微量结果。92例微量阳性者中,培养确诊结核占14%(13/92),广义微生物学标准占24%(22/92),结合临床诊断占26%(24/92)。多数微量阳性者无微生物学确诊结核,但症状和胸部CT异常多于Ultra阴性者。
要点
- 社区筛查中Ultra微量阳性者培养确诊结核仅14%(13/92)。
- 微量阳性者咳嗽32%和CT异常26%均高于Ultra阴性者的对应比例。
- 微量阳性合并微生物学确诊者CT异常达95%,高于未确诊者的54%。
核心结论
- 乌干达社区中多数Ultra微量阳性者无微生物学确诊结核,但症状和胸部CT异常多于Ultra阴性者。
研究设计与样本
- 在乌干达坎帕拉通过入户和活动式痰液收集,对≥15岁成人及青少年进行系统性Ultra结核筛查。
- 纳入微量阳性痰标本者进行临床、影像学和微生物学评估,并与Ultra阴性和Ultra阳性(非微量)对照比较。
主要发现
- 21957例筛查者中211例(1.0%)Ultra阳性,其中96例(占阳性46%)为微量结果。
- 92例微量阳性入组者中,12%(11/92)HIV阳性,14%(13/92)有既往结核史。
- 微量阳性者结核患病率:培养14%(13/92),广义微生物学标准24%(22/92),结合临床诊断26%(24/92)。
- 咳嗽和胸部CT异常比例:Ultra阴性者32%和26%,微量阳性/未微生物学确诊者34%和54%,微量阳性/微生物学确诊者72%和95%,Ultra阳性(非微量)者71%和93%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: "Trace" results on Xpert MTB/RIF Ultra ("Ultra"; Cepheid) -a molecular diagnostic test for tuberculosis (TB)-are often interpreted as an indication for TB treatment, but may also represent detection of nonviable bacilli or analytical error. In community-screening settings where individual TB risk is low, there is limited guidance on how to interpret Ultra-trace results. METHODS: We conducted systematic Ultra TB screening of adults and adolescents (≥15 years) in Kampala, Uganda, through door-to-door and event-based sputum collection. We enrolled individuals with trace-positive sputum for detailed clinical, radiographic, and microbiological (including 2 sputum cultures, repeat Ultra, and for people with HIV, urine lipoarabinomannan) evaluation, and compared those findings with similar evaluations in controls with Ultra-negative and Ultra-positive (non-trace) sputum. RESULTS: Of 21 957 people screened with Ultra, 211 (1.0%) tested positive, including 96 (46% of positives) with trace results. Of 92 people enrolled with trace-positive sputum; 12% (11/92) were HIV-positive and 14% (13/92) had prior TB. The prevalence of TB among participants with trace-positive sputum results was 14% (13/92) by culture, 24% (22/92) using broader microbiological criteria, and 26% (24/92) after accounting for clinical diagnosis. The prevalence of cough and of abnormal chest computed tomography (CT) findings were 32% and 26%, respectively, if Ultra-negative; 34% and 54% if trace-positive/non-microbiologically confirmed; 72% and 95% if trace-positive/microbiologically confirmed; and 71% and 93% if Ultra-positive (more than trace). CONCLUSIONS: Most individuals with trace-positive sputum in Ugandan communities did not have microbiologically confirmed TB but had more symptoms and chest CT abnormalities than people with Ultra-negative sputum.
引用
- Sung J, Nantale M, Nalutaaya A, et al. Evidence for Tuberculosis in Individuals With Xpert Ultra "Trace" Sputum During Screening of High-Burden Communities. Clin Infect Dis. 2024. PMID: 37787077. doi:10.1093/cid/ciad595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。